N-methyl-N-(2-methylcyclohexyl)piperidin-4-amine
- $65 - $390
- Product name: N-methyl-N-(2-methylcyclohexyl)piperidin-4-amine
- CAS: 1119452-90-2
- MF: C13H26N2
- MW: 210.36
- EINECS:
- MDL Number:MFCD12027204
- Synonyms:N-methyl-N-(2-methylcyclohexyl)piperidin-4-amine(SALTDATA: FREE);N-methyl-N-(2-methylcyclohexyl)piperidin-4-amine;4-Piperidinamine, N-methyl-N-(2-methylcyclohexyl)-
4 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- Matrix Scientific
- TRC
Package
- 50mg
- 500mg
- 1g
- ManufacturerAK Scientific
- Product number8891AC
- Product descriptionN-Methyl-N-(2-methylcyclohexyl)piperidin-4-amine
- Packaging500mg
- Price$390
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11350502
- Product descriptionN-Methyl-N-(2-methylcyclohexyl)piperidin-4-amine 95+%
- Packaging1g
- Price$297
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number037793
- Product descriptionN-Methyl-N-(2-methylcyclohexyl)piperidin-4-amine
- Packaging500mg
- Price$252
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM334765
- Product descriptionN-Methyl-N-(2-methylcyclohexyl)piperidin-4-amine
- Packaging50mg
- Price$65
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 8891AC | N-Methyl-N-(2-methylcyclohexyl)piperidin-4-amine | 500mg | $390 | 2021-12-16 | Buy |
Crysdot | CD11350502 | N-Methyl-N-(2-methylcyclohexyl)piperidin-4-amine 95+% | 1g | $297 | 2021-12-16 | Buy |
Matrix Scientific | 037793 | N-Methyl-N-(2-methylcyclohexyl)piperidin-4-amine | 500mg | $252 | 2021-12-16 | Buy |
TRC | M334765 | N-Methyl-N-(2-methylcyclohexyl)piperidin-4-amine | 50mg | $65 | 2021-12-16 | Buy |
Properties
Boiling point :280.9±8.0 °C(Predicted)
Density :0.94±0.1 g/cm3(Predicted)
pka :10.68±0.20(Predicted)
Density :0.94±0.1 g/cm3(Predicted)
pka :10.68±0.20(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|